What Treatments Should be Skipped or Intensified in Localized Rectal Cancer?

References

• Blomqvist L , GlimeliusB. The ‘good’, the ‘bad’, and the ‘ugly’ rectal cancers. Acta Oncol.47(1), 5–8 (2008).
   PubMed Web of Science ®Google Scholar
• Braendengen M , TveitKM, BerglundÅet al. A randomized Phase III study (LARCS) comparing preoperative radiotherapy alone versus chemoradiotherapy in non-resectable rectal cancer. J. Clin. Oncol.26(22), 3687–3694 (2008).
   PubMed Web of Science ®Google Scholar
• Glynne-Jones R , WyrwiczL, TiretEet al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol.28(Suppl. 4), iv22–iv40 (2017).
   PubMedGoogle Scholar
• Bosset JF , ColletteL, CalaisGet al. Chemotherapy with preoperative radiotherapy in rectal cancer. N. Engl. J. Med.355(11), 1114–1123 (2006).
   PubMed Web of Science ®Google Scholar
• Gerard JP , ConroyT, BonnetainFet al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J. Clin. Oncol.24(28), 4620–4625 (2006).
   PubMed Web of Science ®Google Scholar
• Glimelius B , MyklebustTå, LundqvistK, WibeA, GurenMG. Two countries: two treatment strategies for rectal cancer. Radiother. Oncol.121(3), 357–363 (2016).
   PubMed Web of Science ®Google Scholar
• Habr-Gama A , PerezRO, KissDRet al. Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations. Hepatogastroenterology51(60), 1703–1707 (2004).
   PubMedGoogle Scholar
• Habr-Gama A , Sao JuliaoGP, VailatiBBet al. Organ preservation in cT2N0 rectal cancer after neoadjuvant chemoradiation therapy: the impact of radiation therapy dose-escalation and consolidation chemotherapy. Ann. Surg. doi:10.1097/SLA.0000000000002447 (2017) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Marijnen CA . Organ preservation in rectal cancer: have all questions been answered?Lancet Oncol.16(1), e13–e22 (2015).
   PubMed Web of Science ®Google Scholar
• NCCN Clinical Practice Guidelines in Oncology RC . www.nccn.org/professionals/physician_gls/f_guidelines.asp#rectal.
   Google Scholar
• Wibe A , CarlsenE, DahlOet al. Nationwide quality assurance of rectal cancer treatment. Colorectal Dis.8(3), 224–229 (2006).
   PubMed Web of Science ®Google Scholar
• Martling A , HolmT, RutqvistLEet al. Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br. J. Surg.92(2), 225–229 (2005).
   PubMed Web of Science ®Google Scholar
• Glimelius B . Multidisciplinary treatment of patients with rectal cancer: development during the past decades and plans for the future. Ups. J. Med. Sci.117(2), 225–236 (2012).
   PubMed Web of Science ®Google Scholar
• Thornqvist S , HysingLB, TuomikoskiLet al. Adaptive radiotherapy strategies for pelvic tumors: a systematic review of clinical implementations. Acta Oncol.55(8), 943–958 (2016).
   PubMed Web of Science ®Google Scholar
• Hall MD , SchultheissTE, SmithDD, FakihMG, WongJYC, ChenYJ. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy. Acta Oncol.55(12), 1392–1399 (2016).
   PubMed Web of Science ®Google Scholar
• Radu C , NorrlidO, BraendengenM, HanssonK, IsacssonU, GlimeliusB. Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients. Acta Oncol.52(3), 528–537 (2013).
   PubMed Web of Science ®Google Scholar
• Glimelius B . On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery. Ups. J. Med. Sci.122(1), 1–10 (2017).
   PubMed Web of Science ®Google Scholar
• Erlandsson J , HolmT, PetterssonDet al. The Stockholm III trial on optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer – a randomised controlled trial. Lancet Oncol.18(3), 336–346 (2017).
   PubMed Web of Science ®Google Scholar
• Glimelius B , MartlingA. What conclusions can be drawn from the Stockholm III rectal cancer trial in the era of watch and wait?Acta Oncol.56(9), 1139–1142 (2017).
   PubMed Web of Science ®Google Scholar
• Tyc-Szczepaniak D , WyrwiczL, WisniowskaK, MichalskiW, PietrzakL, BujkoK. Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: long-term results of a Phase II study. Acta Oncol.55(11), 1369–1370 (2016).
   PubMed Web of Science ®Google Scholar
• Cameron MG , KerstenC, VistadIet al. Palliative pelvic radiotherapy for symptomatic rectal cancer: a prospective multicenter study. Acta Oncol.55(12), 1400–1407 (2016).
   PubMed Web of Science ®Google Scholar
• Pahlman LA , HohenbergerWM, MatzelK, SugiharaK, QuirkeP, GlimeliusB. Should the benefit of adjuvant chemotherapy in colon cancer be re-evaluated?J. Clin. Oncol.34(12), 1297–1299 (2016).
   PubMed Web of Science ®Google Scholar
• Bockelman C , GlimeliusB. Need for adjuvant chemotherapy after colon cancer surgery: has it decreased?Acta Oncol.56(5), 629–633 (2017).
   PubMed Web of Science ®Google Scholar
• Breugom AJ , SwetsM, BossetJFet al. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data. Lancet Oncol.16(2), 200–207 (2015).
   PubMed Web of Science ®Google Scholar
• Bujko K , GlimeliusB, ValentiniV, MichalskiW, SpalekM. Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: a meta-analysis of randomized trials comparing surgery +/− a fluoropyrimidine and surgery + a fluoropyrimidine +/− oxaliplatin. Eur. J. Surg. Oncol.41(6), 713–723 (2015).
   PubMed Web of Science ®Google Scholar
• Nilsson PJ , Van EttenB, HospersGAPet al. Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer: the RAPIDO trial. BMC Cancer13, 279 (2013).
   PubMed Web of Science ®Google Scholar
• Bujko K , WyrwiczL, RutkowskiAet al. Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized Phase III study. Ann. Oncol.27(5), 834–842 (2016).
   PubMed Web of Science ®Google Scholar
• Jin J , LiuS, ZhuYet al. 5×5Gy and consolidation chemotherapy vs long-course preoperative chemoradiation for locally advanced rectal cancer: an interim analysis of a randomized Phase III study. J. Clin. Oncol.35(Suppl. 15), doi:10.1200/JCO.2017.35.15_suppl.e15006 (2017) ( Epub ahead of print).
   Google Scholar
• Joye I , DebucquoyA, FieuwsSet al. Can clinical factors be used as a selection tool for an organ-preserving strategy in rectal cancer? Acta Oncol. 55(8), 1047–1052 (2016).
   PubMed Web of Science ®Google Scholar